asks patients to indicate on a scale of 1 to 5 (1=never; 5=always) how frequently 5 statements relating to habits of medication administration apply to them. Total score (range 5-25) was tabulated by aggregating responses across the 5 statements. Lower scores indicated greater medication adherence. For this survey, a score of 5 to 7 was considered a high level of adherence; a score of 8 to 14 was considered a medium level of adherence, and a score of 15 or higher was considered a low level of adherence.
The Modified Medical Research Council Dyspnea Scale, or mMRC, was used as an assessment of COPD symptom severity. 7, 8 Patients were asked to rate their level of dyspnea on a scale of 0 to 4 based on the degree of disability that dyspnea poses on everyday activities. Higher scores indicated a higher degree of dyspnea. Health care beliefs were assessed on a 5-point Likert-type scale, where patients were presented 15 statements about attitudes and experiences with medical care and asked to indicate how frequently each statement applies to them (1=frequently, 5=always).
Response Rates
As indicated in the main body of the manuscript, the response rates for the HCP and COPD patient surveys are 18% and 65% respectively. Response rates for this study are calculated as follows: number of complete and usable responses/total individuals qualifying for participation in the study.
HCP response rates.
All HCPs who received the invitation and link to participate in the study qualified by definition of their medical specialty/field. Thus, the denominator for calculating the HCP response rate is the total number of individuals who received the invitation. The numerator is the number of complete and usable responses. To assess any potential skew among respondents that might impact the survey results, a subsequent analysis of profiling variables was conducted that compared survey respondents to non-respondents in the sampling frame. Data regarding age, practice setting (e.g. community-based vs. academic medical center-based) and geography from the CHEST member data base were appended to records of survey respondents and sampling frame non-respondents. These data were analyzed to identify any differences in the profiles of these two groups. The results of this analysis demonstrated only minor numeric differences in the profiles of the survey respondents and non-respondents, minimizing the risk of bias in the survey results due to a skew in who responded to the survey.
Discussion of COPD patient response rates. COPD patients were accessed via syndicated research panels. Potential respondents were targeted to receive the invitation and survey link on the basis of age, and in a limited number of cases, based on data collected by the panel company where the potential respondent had previously self-reported a COPD diagnosis. As such, unlike the HCP survey, we have no way of knowing whether or not a particular individual who received an invitation to participate in the survey would actually qualify as a respondent (on the basis of having COPD). Therefore, the denominator for the COPD patient response rate calculation is all individuals who entered the survey and qualified (meaning they reported having a COPD diagnosis in the screening question at the beginning of the survey). The numerator is all complete, usable responses.
e-Figure 1: Delivery Makes a Difference -Health Care Providers' Survey
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Please note: Questions marked "Omitted" were placeholders to simplify programming instructions for this web-based survey and remind reviewers that questions had been eliminated during the survey design phase. All survey questions visible to the survey respondents are presented in this document.
The American College of Chest Physicians (CHEST) is conducting a survey of health care providers on the topic of COPD management and medication adherence. CHEST is not selling anything and would simply like to understand your opinions as part of an industry study to advance patient adherence to treatment plans and help improve the quality of life for people living with COPD. Your answers will be completely confidential and you will not be contacted in the future about your responses.
SCREENING AND PROFILING
Q. Q.17 How important is the inhalation device in determining which medication you will prescribe to a newly diagnosed, stable COPD patient?
Highly important 1
Somewhat important 2
Neither important nor unimportant 3
Not very important 4
Not at all important 5 Q.18 How important is the inhalation device in determining which medication you will prescribe to a newly diagnosed COPD patient who is post exacerbation?
Highly important 1 Somewhat important 2
Not very important 4
Not at all important Training on the patient's actual device 4
Use of placebo devices to observe and teach patients on proper technique 5
Videos 6
Printed materials 7
Use of stickers/labels applied to the device with device-specific instructions Please note: Questions marked "Omitted" were placeholders to simplify programming instructions for this web-based survey and remind reviewers that questions had been eliminated during the survey design phase. All questions visible to the survey respondents are presented in this document.
We are conducting a survey on medical issues and would like to include your opinions. We are not selling anything and would simply like to understand your opinions. Your answers and comments will be completely confidential.
SCREENING AND PROFILING
Q. Q.56 In general, when your doctor changes your COPD medication, is that change being made so that you will be taking a medication that will work better or so that you will be using a device that is easier to operate? 
